Which has higher valuation & earnings, FIVN or CTEV?

Five9 has higher revenue and earnings than Claritev. Claritev is trading at a lower price-to-earnings ratio than Five9, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Five9 $1.15B 1.54 $39.42M $0.66 35.02 Claritev $965.41M 0.39 -$284.28M -$17.33 N/A

Is FIVN or CTEV more profitable?

Five9 has a net margin of 4.87% compared to Claritev's net margin of -29.27%. Five9's return on equity of 12.66% beat Claritev's return on equity. Company Net Margins Return on Equity Return on Assets Five9 4.87% 12.66% 5.52% Claritev -29.27% N/A -4.36%

Does the media prefer FIVN or CTEV?

In the previous week, Five9 had 4 more articles in the media than Claritev. MarketBeat recorded 8 mentions for Five9 and 4 mentions for Claritev. Five9's average media sentiment score of 1.16 beat Claritev's score of 0.66 indicating that Five9 is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Five9 4 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Claritev 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings & valuation, NEO or CTEV?

NeoGenomics has higher earnings, but lower revenue than Claritev. NeoGenomics is trading at a lower price-to-earnings ratio than Claritev, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio NeoGenomics $727.33M 2.49 -$108.03M -$0.77 N/A Claritev $965.41M 0.39 -$284.28M -$17.33 N/A

Is NEO or CTEV more profitable?

NeoGenomics has a net margin of -13.30% compared to Claritev's net margin of -29.27%. Claritev's return on equity of 0.00% beat NeoGenomics' return on equity. Company Net Margins Return on Equity Return on Assets NeoGenomics -13.30% -2.80% -1.72% Claritev -29.27% N/A -4.36%

Does the media refer more to NEO or CTEV?

In the previous week, NeoGenomics had 7 more articles in the media than Claritev. MarketBeat recorded 11 mentions for NeoGenomics and 4 mentions for Claritev. Claritev's average media sentiment score of 0.66 beat NeoGenomics' score of 0.28 indicating that Claritev is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NeoGenomics 3 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Claritev 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation & earnings, PRG or CTEV?

PROG has higher revenue and earnings than Claritev. Claritev is trading at a lower price-to-earnings ratio than PROG, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio PROG $2.41B 0.72 $146.79M $3.66 11.90 Claritev $965.41M 0.39 -$284.28M -$17.33 N/A

Is PRG or CTEV more profitable?

PROG has a net margin of 5.88% compared to Claritev's net margin of -29.27%. PROG's return on equity of 21.94% beat Claritev's return on equity. Company Net Margins Return on Equity Return on Assets PROG 5.88% 21.94% 9.54% Claritev -29.27% N/A -4.36%

Does the media refer more to PRG or CTEV?

In the previous week, PROG and PROG both had 4 articles in the media. Claritev's average media sentiment score of 0.66 beat PROG's score of 0.41 indicating that Claritev is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PROG 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Claritev 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings and valuation, EVTC or CTEV?

Evertec has higher earnings, but lower revenue than Claritev. Claritev is trading at a lower price-to-earnings ratio than Evertec, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Evertec $950.95M 1.93 $141.59M $2.07 14.36 Claritev $965.41M 0.39 -$284.28M -$17.33 N/A

Is EVTC or CTEV more profitable?

Evertec has a net margin of 13.95% compared to Claritev's net margin of -29.27%. Evertec's return on equity of 31.40% beat Claritev's return on equity. Company Net Margins Return on Equity Return on Assets Evertec 13.95% 31.40% 9.36% Claritev -29.27% N/A -4.36%

Does the media prefer EVTC or CTEV?

In the previous week, Evertec had 3 more articles in the media than Claritev. MarketBeat recorded 7 mentions for Evertec and 4 mentions for Claritev. Claritev's average media sentiment score of 0.66 beat Evertec's score of 0.00 indicating that Claritev is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Evertec 2 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Claritev 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation and earnings, STGW or CTEV?

Stagwell has higher revenue and earnings than Claritev. Claritev is trading at a lower price-to-earnings ratio than Stagwell, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Stagwell $2.91B 0.63 $29.10M $0.07 106.07 Claritev $965.41M 0.39 -$284.28M -$17.33 N/A

Is STGW or CTEV more profitable?

Stagwell has a net margin of 0.64% compared to Claritev's net margin of -29.27%. Stagwell's return on equity of 24.12% beat Claritev's return on equity. Company Net Margins Return on Equity Return on Assets Stagwell 0.64% 24.12% 4.31% Claritev -29.27% N/A -4.36%

Does the media prefer STGW or CTEV?

In the previous week, Claritev had 2 more articles in the media than Stagwell. MarketBeat recorded 4 mentions for Claritev and 2 mentions for Stagwell. Claritev's average media sentiment score of 0.66 beat Stagwell's score of 0.34 indicating that Claritev is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Stagwell 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Claritev 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Claritev (CTEV) Competitors

$21.98 -1.29 (-5.54%)

As of 03:45 PM Eastern

Compare

CTEV vs. FIVN, NEO, PRG, EVTC, and STGW

Should you buy Claritev stock or one of its competitors? MarketBeat compares Claritev with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Claritev include Five9 (FIVN), NeoGenomics (NEO), PROG (PRG), Evertec (EVTC), and Stagwell (STGW). These companies are all part of the "business services" industry.

How does Claritev compare to Five9?

Five9 (NASDAQ:FIVN) and Claritev (NYSE:CTEV) are both small-cap business services companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, analyst recommendations, risk, dividends, media sentiment and valuation.

Five9 currently has a consensus target price of $25.93, indicating a potential upside of 12.17%. Claritev has a consensus target price of $34.50, indicating a potential upside of 56.96%. Given Claritev's higher probable upside, analysts clearly believe Claritev is more favorable than Five9.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Five9	1 Sell rating(s)	6 Hold rating(s)	10 Buy rating(s)	1 Strong Buy rating(s)	2.61
Claritev	2 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.38

Five9 has a net margin of 4.87% compared to Claritev's net margin of -29.27%. Five9's return on equity of 12.66% beat Claritev's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Five9	4.87%	12.66%	5.52%
Claritev	-29.27%	N/A	-4.36%

Five9 has a beta of 1.46, indicating that its share price is 46% more volatile than the broader market. Comparatively, Claritev has a beta of 0.69, indicating that its share price is 31% less volatile than the broader market.

96.6% of Five9 shares are held by institutional investors. Comparatively, 87.2% of Claritev shares are held by institutional investors. 1.2% of Five9 shares are held by company insiders. Comparatively, 7.4% of Claritev shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Five9 has higher revenue and earnings than Claritev. Claritev is trading at a lower price-to-earnings ratio than Five9, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Five9	$1.15B	1.54	$39.42M	$0.66	35.02
Claritev	$965.41M	0.39	-$284.28M	-$17.33	N/A

In the previous week, Five9 had 4 more articles in the media than Claritev. MarketBeat recorded 8 mentions for Five9 and 4 mentions for Claritev. Five9's average media sentiment score of 1.16 beat Claritev's score of 0.66 indicating that Five9 is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Five9	4 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Claritev	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Five9 beats Claritev on 15 of the 17 factors compared between the two stocks.

How does Claritev compare to NeoGenomics?

NeoGenomics (NASDAQ:NEO) and Claritev (NYSE:CTEV) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends, media sentiment and valuation.

NeoGenomics has a net margin of -13.30% compared to Claritev's net margin of -29.27%. Claritev's return on equity of 0.00% beat NeoGenomics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NeoGenomics	-13.30%	-2.80%	-1.72%
Claritev	-29.27%	N/A	-4.36%

NeoGenomics currently has a consensus price target of $14.57, indicating a potential upside of 4.85%. Claritev has a consensus price target of $34.50, indicating a potential upside of 56.96%. Given Claritev's higher probable upside, analysts clearly believe Claritev is more favorable than NeoGenomics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeoGenomics	1 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.42
Claritev	2 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.38

NeoGenomics has higher earnings, but lower revenue than Claritev. NeoGenomics is trading at a lower price-to-earnings ratio than Claritev, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NeoGenomics	$727.33M	2.49	-$108.03M	-$0.77	N/A
Claritev	$965.41M	0.39	-$284.28M	-$17.33	N/A

In the previous week, NeoGenomics had 7 more articles in the media than Claritev. MarketBeat recorded 11 mentions for NeoGenomics and 4 mentions for Claritev. Claritev's average media sentiment score of 0.66 beat NeoGenomics' score of 0.28 indicating that Claritev is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NeoGenomics	3 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral
Claritev	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

98.5% of NeoGenomics shares are owned by institutional investors. Comparatively, 87.2% of Claritev shares are owned by institutional investors. 1.1% of NeoGenomics shares are owned by insiders. Comparatively, 7.4% of Claritev shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

NeoGenomics has a beta of 1.74, suggesting that its stock price is 74% more volatile than the broader market. Comparatively, Claritev has a beta of 0.69, suggesting that its stock price is 31% less volatile than the broader market.

Summary

NeoGenomics beats Claritev on 10 of the 16 factors compared between the two stocks.

How does Claritev compare to PROG?

PROG (NYSE:PRG) and Claritev (NYSE:CTEV) are both small-cap business services companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, dividends, institutional ownership, profitability, media sentiment and earnings.

97.9% of PROG shares are owned by institutional investors. Comparatively, 87.2% of Claritev shares are owned by institutional investors. 3.7% of PROG shares are owned by company insiders. Comparatively, 7.4% of Claritev shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

PROG has a net margin of 5.88% compared to Claritev's net margin of -29.27%. PROG's return on equity of 21.94% beat Claritev's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PROG	5.88%	21.94%	9.54%
Claritev	-29.27%	N/A	-4.36%

PROG has higher revenue and earnings than Claritev. Claritev is trading at a lower price-to-earnings ratio than PROG, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PROG	$2.41B	0.72	$146.79M	$3.66	11.90
Claritev	$965.41M	0.39	-$284.28M	-$17.33	N/A

In the previous week, PROG and PROG both had 4 articles in the media. Claritev's average media sentiment score of 0.66 beat PROG's score of 0.41 indicating that Claritev is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PROG	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Claritev	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

PROG has a beta of 1.78, suggesting that its share price is 78% more volatile than the broader market. Comparatively, Claritev has a beta of 0.69, suggesting that its share price is 31% less volatile than the broader market.

PROG presently has a consensus target price of $47.36, indicating a potential upside of 8.73%. Claritev has a consensus target price of $34.50, indicating a potential upside of 56.96%. Given Claritev's higher possible upside, analysts plainly believe Claritev is more favorable than PROG.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PROG	0 Sell rating(s)	4 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.56
Claritev	2 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.38

Summary

PROG beats Claritev on 11 of the 14 factors compared between the two stocks.

How does Claritev compare to Evertec?

Evertec (NYSE:EVTC) and Claritev (NYSE:CTEV) are both small-cap business services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, institutional ownership, valuation, earnings, dividends and media sentiment.

Evertec has a net margin of 13.95% compared to Claritev's net margin of -29.27%. Evertec's return on equity of 31.40% beat Claritev's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Evertec	13.95%	31.40%	9.36%
Claritev	-29.27%	N/A	-4.36%

Evertec presently has a consensus price target of $32.75, indicating a potential upside of 10.18%. Claritev has a consensus price target of $34.50, indicating a potential upside of 56.96%. Given Claritev's stronger consensus rating and higher possible upside, analysts clearly believe Claritev is more favorable than Evertec.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Evertec	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17
Claritev	2 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.38

In the previous week, Evertec had 3 more articles in the media than Claritev. MarketBeat recorded 7 mentions for Evertec and 4 mentions for Claritev. Claritev's average media sentiment score of 0.66 beat Evertec's score of 0.00 indicating that Claritev is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Evertec	2 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Claritev	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Evertec has higher earnings, but lower revenue than Claritev. Claritev is trading at a lower price-to-earnings ratio than Evertec, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Evertec	$950.95M	1.93	$141.59M	$2.07	14.36
Claritev	$965.41M	0.39	-$284.28M	-$17.33	N/A

Evertec has a beta of 0.71, meaning that its share price is 29% less volatile than the broader market. Comparatively, Claritev has a beta of 0.69, meaning that its share price is 31% less volatile than the broader market.

96.8% of Evertec shares are owned by institutional investors. Comparatively, 87.2% of Claritev shares are owned by institutional investors. 1.1% of Evertec shares are owned by insiders. Comparatively, 7.4% of Claritev shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Evertec beats Claritev on 10 of the 16 factors compared between the two stocks.

How does Claritev compare to Stagwell?

Stagwell (NASDAQ:STGW) and Claritev (NYSE:CTEV) are both small-cap business services companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, media sentiment, dividends, earnings, valuation and risk.

Stagwell has higher revenue and earnings than Claritev. Claritev is trading at a lower price-to-earnings ratio than Stagwell, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Stagwell	$2.91B	0.63	$29.10M	$0.07	106.07
Claritev	$965.41M	0.39	-$284.28M	-$17.33	N/A

Stagwell has a net margin of 0.64% compared to Claritev's net margin of -29.27%. Stagwell's return on equity of 24.12% beat Claritev's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Stagwell	0.64%	24.12%	4.31%
Claritev	-29.27%	N/A	-4.36%

Stagwell has a beta of 1.26, meaning that its stock price is 26% more volatile than the broader market. Comparatively, Claritev has a beta of 0.69, meaning that its stock price is 31% less volatile than the broader market.

In the previous week, Claritev had 2 more articles in the media than Stagwell. MarketBeat recorded 4 mentions for Claritev and 2 mentions for Stagwell. Claritev's average media sentiment score of 0.66 beat Stagwell's score of 0.34 indicating that Claritev is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Stagwell	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Claritev	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

35.6% of Stagwell shares are owned by institutional investors. Comparatively, 87.2% of Claritev shares are owned by institutional investors. 11.2% of Stagwell shares are owned by company insiders. Comparatively, 7.4% of Claritev shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Stagwell currently has a consensus price target of $7.80, indicating a potential upside of 5.05%. Claritev has a consensus price target of $34.50, indicating a potential upside of 56.96%. Given Claritev's higher probable upside, analysts clearly believe Claritev is more favorable than Stagwell.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Stagwell	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43
Claritev	2 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.38

Summary

Stagwell beats Claritev on 11 of the 16 factors compared between the two stocks.

Get Claritev News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CTEV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CTEV vs. The Competition

Export

Metric	Claritev	Business services Industry	Medical Sector	NYSE Exchange
Market Cap	$374.76M	$1.72B	$6.88B	$23.51B
Dividend Yield	N/A	4.42%	2.68%	4.18%
P/E Ratio	-1.27	115.47	26.87	30.66
Price / Sales	0.39	4.87	525.55	19.31
Price / Cash	1.62	6.58	50.43	32.27
Price / Book	-2.18	6.86	10.28	4.74
Net Income	-$284.28M	$7.28M	$3.60B	$1.07B
7 Day Performance	-27.12%	-4.42%	-1.16%	-0.43%
1 Month Performance	-27.24%	-1.07%	-0.46%	0.91%
1 Year Performance	-49.75%	-8.23%	19.02%	14.27%

Claritev Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CTEV Claritev	3.8397 of 5 stars	$21.98 -5.5%	$34.50 +57.0%	-45.8%	$374.76M	$965.41M	N/A	3,000	Analyst Forecast
FIVN Five9	4.3226 of 5 stars	$25.58 +1.3%	$25.93 +1.4%	-25.4%	$1.93B	$1.15B	38.76	2,910	Positive News Gap Up
NEO NeoGenomics	1.7037 of 5 stars	$14.61 -1.5%	$13.86 -5.2%	+115.4%	$1.93B	$727.33M	N/A	2,500	Upcoming Earnings Analyst Forecast High Trading Volume
PRG PROG	3.3826 of 5 stars	$46.47 -2.2%	$47.36 +1.9%	+30.1%	$1.90B	$2.41B	12.70	1,151	Upcoming Earnings
EVTC Evertec	4.1903 of 5 stars	$30.27 -1.7%	$32.75 +8.2%	-13.3%	$1.90B	$931.82M	14.62	5,327	News Coverage Dividend Announcement

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:CTEV) was last updated on 7/24/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Claritev (CTEV) Competitors